Close
CDMO Safety Testing 2026
Novotech

PHASTAR Launches Pro-Bono Scheme for Charities

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration...

VoxCell and adMare Partner on Antibody Therapy Research

VoxCell BioInnovation Inc. and adMare BioInnovations have entered a...
- Advertisement -

PHASTAR, aย global specialist biometrics contract research organization (CRO), has announced the launch of a pro-bono scheme to give charities access to its volunteer statisticians, data scientists, data managers and programmers at no cost.

PHASTAR Cares allows third-sector organisations to fulfil their charitable aims by providing biometrics support they may otherwise be unable to afford. The team of experts can advise on data collection, analysis and dissemination.

Andrew MacGarvey, CEO commented: โ€œPHASTARโ€™s experts are thought leaders who can use the right tools to help charities gain important insight. They are excellent communicators, adept at understanding the needs of the client, and can help charities extract the most value from their data. PHASTAR Cares is a tailor-made service, increasing understanding of data and evidence to aid decision making.โ€

One of the first charities to sign up to PHASTAR Cares is Education for Health (EfH). Establishedย in 1987, the UK-based charity aims to improve standards of healthcare by providing training and resources for thousands of healthcare professionals seeking continuous improvement ofย patient outcomes and the reduction of care inequality.

In partnership with EfH, PHASTARย is developing a profiling toolย designed to help GP practices to improve detection and treatment of patients in a number of common disease types. By using anonymised patient data provided from EfH-partnered GP practices, PHASTAR’s live dashboard will enable GP practicesย to access the data at any time. This allows them to directly monitor and profile their patient populations on an ongoing basis and target interventions and services effectively.

โ€œEducation for Health is delighted to be working with Phastar โ€“ their biometric expertise and patience is enabling us to fulfil our primary aim of supporting primary care professionals to improve health outcomes. The focus of our collaboration will enable practices to easily identify the people most at risk in a range of long-term conditions.ย  We are privileged to be the first charity to work with them in this wayโ€ says Dr Linda Edwards, Chief Executive of Education Health.

To be eligible for support through the PHASTAR Cares pro-bono scheme, organisations must be recognised as third sector and typically have an annual turnover of up to ยฃ2.5m.

PHASTAR has an active charitable programme and supports The Red Cross, amongst others, through a number of initiatives throughout the year.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration...

VoxCell and adMare Partner on Antibody Therapy Research

VoxCell BioInnovation Inc. and adMare BioInnovations have entered a...

Avenda Health Expands Unfold AI Into Midwest Cancer Care

Avenda Health said the University of Michigan Health Weiser...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป